Differential expression of colon cancer associated transcript1 (CCAT1) along the colonic adenoma-carcinoma sequence - PubMed (original) (raw)
Comparative Study
doi: 10.1186/1471-2407-13-196.
Nadia Ilyayev, Alexander Stojadinovic, Mina Izadjoo, Marina Roistacher, Vera Pavlov, Victoria Tzivin, David Halle, Honguang Pan, Barry Trink, Ali O Gure, Aviram Nissan
- PMID: 23594791
- PMCID: PMC3639026
- DOI: 10.1186/1471-2407-13-196
Comparative Study
Differential expression of colon cancer associated transcript1 (CCAT1) along the colonic adenoma-carcinoma sequence
Bilal Alaiyan et al. BMC Cancer. 2013.
Abstract
Background: The transition from normal epithelium to adenoma and, to invasive carcinoma in the human colon is associated with acquired molecular events taking 5-10 years for malignant transformation. We discovered CCAT1, a non-coding RNA over-expressed in colon cancer (CC), but not in normal tissues, thereby making it a potential disease-specific biomarker. We aimed to define and validate CCAT1 as a CC-specific biomarker, and to study CCAT1 expression across the adenoma-carcinoma sequence of CC tumorigenesis.
Methods: Tissue samples were obtained from patients undergoing resection for colonic adenoma(s) or carcinoma. Normal colonic tissue (n = 10), adenomatous polyps (n = 18), primary tumor tissue (n = 22), normal mucosa adjacent to primary tumor (n = 16), and lymph node(s) (n = 20), liver (n = 8), and peritoneal metastases (n = 19) were studied. RNA was extracted from all tissue samples, and CCAT1 expression was analyzed using quantitative real time-PCR (qRT-PCR) with confirmatory in-situ hybridization (ISH).
Results: Borderline expression of CCAT1 was identified in normal tissue obtained from patients with benign conditions [mean Relative Quantity (RQ) = 5.9]. Significant relative CCAT1 up-regulation was observed in adenomatous polyps (RQ = 178.6 ± 157.0; p = 0.0012); primary tumor tissue (RQ = 64.9 ± 56.9; p = 0.0048); normal mucosa adjacent to primary tumor (RQ = 17.7 ± 21.5; p = 0.09); lymph node, liver and peritoneal metastases (RQ = 11,414.5 ± 12,672.9; 119.2 ± 138.9; 816.3 ± 2,736.1; p = 0.0001, respectively). qRT-PCR results were confirmed by ISH, demonstrating significant correlation between CCAT1 up-regulation measured using these two methods.
Conclusion: CCAT1 is up-regulated across the colon adenoma-carcinoma sequence. This up-regulation is evident in pre-malignant conditions and through all disease stages, including advanced metastatic disease suggesting a role in both tumorigenesis and the metastatic process.
Figures
Figure 1
CCAT1 expression analyzed by in-situ hybiridization.In situ hybrdization of CCAT1 was analyzed in normal colonic tissue (a), normal mucosa adjacent to the primary tumor site (b) and in primary adenocarcinoma of the colon (c). Samples a and b were obtained from the same patient (T877). The probe sequence and topographic location within the CCAT1 gene are outlined in the lower part of the figure.
Figure 2
A logarithmic scale of relative quantity (RQ) of CCAT1 expression in the adenoma-carcinoma sequence. The log RQ of CCAT1 expression is shown for every tissue type: inflamed colonic tissue, normal colon adjacent to the tumor site (Normal Adj.), adenomatous polyps, primary tumor tissue, lymph node metastasis (LN-Mx), liver metastasis (Liver-Mx), and peritoneal metastasis (Peritoneal-Mx). Mean RQ and standard deviation are shown in the lower part of the figure. Mean CCAT1 expression was compared to normal colon. * p < 0.09, ** p = 0.012, ***p = 0.0048, ****p < 0.0001.
Figure 3
A logarithmic scale of relative quantity (RQ) of CCAT1 expression in lymph nodes. The log RQ of CCAT1 expression is shown for benign lymph nodes (white rectangle), lymph nodes without metastasis by histopatholgical examination (gray rectangle), and for lymph nodes with metastasis from the same colon cancer patients (black rectangle). The colon cancer cell line HT29 was used as positive control and a commercially available normal lymphatic tissue was used as a calibrator (LN_NN-Ambion).
Similar articles
- Expression of the antiapoptotic protein survivin in colon cancer.
Hernandez JM, Farma JM, Coppola D, Hakam A, Fulp WJ, Chen DT, Siegel EM, Yeatman TJ, Shibata D. Hernandez JM, et al. Clin Colorectal Cancer. 2011 Sep;10(3):188-93. doi: 10.1016/j.clcc.2011.03.014. Epub 2011 Apr 28. Clin Colorectal Cancer. 2011. PMID: 21855041 Free PMC article. - Metastasis-associated long non-coding RNA drives gastric cancer development and promotes peritoneal metastasis.
Okugawa Y, Toiyama Y, Hur K, Toden S, Saigusa S, Tanaka K, Inoue Y, Mohri Y, Kusunoki M, Boland CR, Goel A. Okugawa Y, et al. Carcinogenesis. 2014 Dec;35(12):2731-9. doi: 10.1093/carcin/bgu200. Epub 2014 Oct 3. Carcinogenesis. 2014. PMID: 25280565 Free PMC article. - Expression of serum amyloid A, in normal, dysplastic, and neoplastic human colonic mucosa: implication for a role in colonic tumorigenesis.
Gutfeld O, Prus D, Ackerman Z, Dishon S, Linke RP, Levin M, Urieli-Shoval S. Gutfeld O, et al. J Histochem Cytochem. 2006 Jan;54(1):63-73. doi: 10.1369/jhc.5A6645.2005. Epub 2005 Aug 22. J Histochem Cytochem. 2006. PMID: 16116035 - A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer.
Saito T, Kurashige J, Nambara S, Komatsu H, Hirata H, Ueda M, Sakimura S, Uchi R, Takano Y, Shinden Y, Iguchi T, Eguchi H, Ehata S, Murakami K, Sugimachi K, Mimori K. Saito T, et al. Ann Surg Oncol. 2015 Dec;22 Suppl 3:S915-22. doi: 10.1245/s10434-015-4554-8. Epub 2015 May 19. Ann Surg Oncol. 2015. PMID: 25986864 - C-Myc-activated long noncoding RNA CCAT1 promotes colon cancer cell proliferation and invasion.
He X, Tan X, Wang X, Jin H, Liu L, Ma L, Yu H, Fan Z. He X, et al. Tumour Biol. 2014 Dec;35(12):12181-8. doi: 10.1007/s13277-014-2526-4. Epub 2014 Sep 4. Tumour Biol. 2014. PMID: 25185650
Cited by
- Non-coding RNAs as therapeutic targets in cancer and its clinical application.
Leng X, Zhang M, Xu Y, Wang J, Ding N, Yu Y, Sun S, Dai W, Xue X, Li N, Yang Y, Shi Z. Leng X, et al. J Pharm Anal. 2024 Jul;14(7):100947. doi: 10.1016/j.jpha.2024.02.001. Epub 2024 Feb 8. J Pharm Anal. 2024. PMID: 39149142 Free PMC article. Review. - Predictors of early colorectal cancer metastasis to lymph nodes: providing rationale for therapy decisions.
Song X, Li J, Zhu J, Kong YF, Zhou YH, Wang ZK, Zhang J. Song X, et al. Front Oncol. 2024 Jul 5;14:1371599. doi: 10.3389/fonc.2024.1371599. eCollection 2024. Front Oncol. 2024. PMID: 39035744 Free PMC article. Review. - Deciphering the Epigenetic Symphony of Cancer: Insights and Epigenetic Therapies Implications.
Akram F, Tanveer R, Andleeb S, Shah FI, Ahmad T, Shehzadi S, Akhtar AM, Syed G. Akram F, et al. Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241250317. doi: 10.1177/15330338241250317. Technol Cancer Res Treat. 2024. PMID: 38780251 Free PMC article. Review. - CCAT1 lncRNA is chromatin-retained and post-transcriptionally spliced.
Bohrer C, Varon E, Peretz E, Reinitz G, Kinor N, Halle D, Nissan A, Shav-Tal Y. Bohrer C, et al. Histochem Cell Biol. 2024 Jul;162(1-2):91-107. doi: 10.1007/s00418-024-02294-w. Epub 2024 May 19. Histochem Cell Biol. 2024. PMID: 38763947 Free PMC article. - CEBPB-mediated upregulation of SERPINA1 promotes colorectal cancer progression by enhancing STAT3 signaling.
Ma Y, Chen Y, Zhan L, Dong Q, Wang Y, Li X, He L, Zhang J. Ma Y, et al. Cell Death Discov. 2024 May 6;10(1):219. doi: 10.1038/s41420-024-01990-9. Cell Death Discov. 2024. PMID: 38710698 Free PMC article.
References
- Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, Jemal A, Schymura MJ, Lansdorp-Vogelaar I, Seeff LC, van Ballegooijen M, Goede SL, Ries LA. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer. 2010;116:544–573. doi: 10.1002/cncr.24760. - DOI - PMC - PubMed
- Edge SB. American Joint Committee on Cancer: AJCC Cancer Staging Manual. 7. New York: Springer; 2010. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical